NL-OMON44627已完成不适用
Pharmacokinetics and metabolism of [14C] BMS-986195 in healthy male subjects - BMS-986195 ADME study
Bristol-Myers Squibb Research and Development0 个研究点目标入组 9 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male subjects,
- •- 18 - 55 years, inclusive
- •- BMI: 18.0 - 32.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Pharmacokinetics and metabolism of [14C]BMS-820836 in healthy male subjectsDepressionanxiety disorders10027946NL-OMON34571Bristol-Myers Squibb6
已完成
1 期
Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020Immunosuppression For DiseaseNCT02068053Bristol-Myers Squibb6
已完成
1 期
Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.HIV InfectionsNCT02206711ViiV Healthcare21
已完成
1 期
Pharmacokinetics and Metabolism Study in Healthy Male ParticipantsCancerNCT03247283Bristol-Myers Squibb9
已完成
1 期
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male ParticipantsPsoriasisNCT03004768Bristol-Myers Squibb6